- Home
- A-Z Publications
- Medicinal Chemistry
- Previous Issues
- Volume 20, Issue 3, 2024
Medicinal Chemistry - Volume 20, Issue 3, 2024
Volume 20, Issue 3, 2024
-
-
Diverse Pharmacological Potential of Pyridazine Analogs against Various Diseases
Authors: Ahad A. Alsaiari, Mazen M. Almehmadi and Mohammad AsifPyridazinone analogs possess diverse types of pharmacological activities, such as anticancer, antimicrobial, anticonvulsant, analgesic, anti-inflammatory, antioxidant, antihypertensive, antisecretory, antiulcer, and other useful pharmacological activities. They also possess cyclooxygenase (COX) inhibitors, dipeptidyl peptidase inhibitors, phosphodiesterase inhibitors, glutamate transporter activators, adenosi Read More
-
-
-
An Overview of Various Rifampicin Analogs against Mycobacterium tuberculosis and their Drug Interactions
Authors: Mohammad Asif, Naeem F. Qusty and Saad AlghamdiThe success of the TB control program is hampered by the major issue of drug-resistant tuberculosis (DR-TB). The situation has undoubtedly been made more difficult by the widespread and multidrug-resistant (XDR) strains of TB. The modification of existing anti-TB medications to produce derivatives that can function on resistant TB bacilli is one of the potential techniques to overcome drug resistance affordably and straigh Read More
-
-
-
Pyrazolo - Pyrimidines as Targeted Anticancer Scaffolds - A Comprehensive Review
More LessBackground: Globally, cancer is the leading cause of death, which causes 10 million deaths yearly. Clinically, several drugs are used in treatment but due to drug resistance and multidrug resistance, there occurs a failure in the cancer treatment. Objectives: The present review article is a comprehensive review of pyrazole and pyrimidine hybrids as potential anticancer agents. Methods: The review comprises more than 60 Read More
-
-
-
A Critical Review on Therapeutic Potential of Benzimidazole Derivatives: A Privileged Scaffold
Benzimidazole nucleus is a predominant heterocycle displaying a wide spectrum of pharmacological activities. The privileged nature of the benzimidazole scaffold has been revealed by its presence in most small molecule drugs and in its ability to bind multiple receptors with high affinity. A literature review of the scaffold reveals several instances where structural modifications of the benzimidazole core have resulted in hi Read More
-
-
-
Unveiling the ESR1 Conformational Stability and Screening Potent Inhibitors for Breast Cancer Treatment
Background: The current study recognizes the significance of estrogen receptor alpha (ERα) as a member of the nuclear receptor protein family, which holds a central role in the pathophysiology of breast cancer. ERα serves as a valuable prognostic marker, with its established relevance in predicting disease outcomes and treatment responses. Methods: In this study, computational methods are utilized to search for suitable Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/mc
Journal
10
5
false
en
